815 related articles for article (PubMed ID: 15651349)
21. Limb apraxia in corticobasal degeneration and progressive supranuclear palsy.
Soliveri P; Piacentini S; Girotti F
Neurology; 2005 Feb; 64(3):448-53. PubMed ID: 15699373
[TBL] [Abstract][Full Text] [Related]
22. Diffusion-weighted brain imaging study of patients with clinical diagnosis of corticobasal degeneration, progressive supranuclear palsy and Parkinson's disease.
Rizzo G; Martinelli P; Manners D; Scaglione C; Tonon C; Cortelli P; Malucelli E; Capellari S; Testa C; Parchi P; Montagna P; Barbiroli B; Lodi R
Brain; 2008 Oct; 131(Pt 10):2690-700. PubMed ID: 18819991
[TBL] [Abstract][Full Text] [Related]
23. Features of Patients With Nonfluent/Agrammatic Primary Progressive Aphasia With Underlying Progressive Supranuclear Palsy Pathology or Corticobasal Degeneration.
Santos-Santos MA; Mandelli ML; Binney RJ; Ogar J; Wilson SM; Henry ML; Hubbard HI; Meese M; Attygalle S; Rosenberg L; Pakvasa M; Trojanowski JQ; Grinberg LT; Rosen H; Boxer AL; Miller BL; Seeley WW; Gorno-Tempini ML
JAMA Neurol; 2016 Jun; 73(6):733-42. PubMed ID: 27111692
[TBL] [Abstract][Full Text] [Related]
24. Clinical and pathologic evidence of corticobasal degeneration and progressive supranuclear palsy in familial tauopathy.
Tuite PJ; Clark HB; Bergeron C; Bower M; St George-Hyslop P; Mateva V; Anderson J; Knopman DS
Arch Neurol; 2005 Sep; 62(9):1453-7. PubMed ID: 16157754
[TBL] [Abstract][Full Text] [Related]
25. Are frontotemporal lobar degeneration, progressive supranuclear palsy and corticobasal degeneration distinct diseases?
Sha S; Hou C; Viskontas IV; Miller BL
Nat Clin Pract Neurol; 2006 Dec; 2(12):658-65. PubMed ID: 17117169
[TBL] [Abstract][Full Text] [Related]
26. Identification of amino-terminally cleaved tau fragments that distinguish progressive supranuclear palsy from corticobasal degeneration.
Arai T; Ikeda K; Akiyama H; Nonaka T; Hasegawa M; Ishiguro K; Iritani S; Tsuchiya K; Iseki E; Yagishita S; Oda T; Mochizuki A
Ann Neurol; 2004 Jan; 55(1):72-9. PubMed ID: 14705114
[TBL] [Abstract][Full Text] [Related]
27. Cortical degeneration in progressive supranuclear palsy. A comparison with cortical-basal ganglionic degeneration.
Bergeron C; Pollanen MS; Weyer L; Lang AE
J Neuropathol Exp Neurol; 1997 Jun; 56(6):726-34. PubMed ID: 9184663
[TBL] [Abstract][Full Text] [Related]
28. [An unusual autopsy case of corticobasal degeneration--with special reference to clinicopathological differentiation from progressive supranuclear palsy and slowly progressive aphasia].
Tsuchiya K; Ikeda K; Watabiki S; Shiozu H; Hashimoto K; Mitani K; Okiyama R; Sano M; Kondo H; Shimada H
No To Shinkei; 1996 Jun; 48(6):559-65. PubMed ID: 8703559
[TBL] [Abstract][Full Text] [Related]
29. Different tau pathology pattern in two clinical phenotypes of progressive supranuclear palsy.
Jellinger KA
Neurodegener Dis; 2008; 5(6):339-46. PubMed ID: 18349518
[TBL] [Abstract][Full Text] [Related]
30. Relationship between frontotemporal dementia and corticobasal degeneration/progressive supranuclear palsy.
Kertesz A; Munoz D
Dement Geriatr Cogn Disord; 2004; 17(4):282-6. PubMed ID: 15178937
[TBL] [Abstract][Full Text] [Related]
31. Action and object naming in frontotemporal dementia, progressive supranuclear palsy, and corticobasal degeneration.
Cotelli M; Borroni B; Manenti R; Alberici A; Calabria M; Agosti C; Arévalo A; Ginex V; Ortelli P; Binetti G; Zanetti O; Padovani A; Cappa SF
Neuropsychology; 2006 Sep; 20(5):558-65. PubMed ID: 16938018
[TBL] [Abstract][Full Text] [Related]
32. Diagnostic accuracy of progressive supranuclear palsy in the Society for Progressive Supranuclear Palsy brain bank.
Josephs KA; Dickson DW
Mov Disord; 2003 Sep; 18(9):1018-26. PubMed ID: 14502669
[TBL] [Abstract][Full Text] [Related]
33. [Progressive supranuclear palsy].
Hasegawa K
Rinsho Shinkeigaku; 1997 Dec; 37(12):1128-30. PubMed ID: 9577667
[TBL] [Abstract][Full Text] [Related]
34. Decreased beta-amyloid peptide42 in cerebrospinal fluid of patients with progressive supranuclear palsy and corticobasal degeneration.
Noguchi M; Yoshita M; Matsumoto Y; Ono K; Iwasa K; Yamada M
J Neurol Sci; 2005 Oct; 237(1-2):61-5. PubMed ID: 15992827
[TBL] [Abstract][Full Text] [Related]
35. [Corticobasal degeneration and progressive supranuclear palsy--biochemical marker].
Urakami K; Nakashima K
Rinsho Shinkeigaku; 2002 Nov; 42(11):1162-4. PubMed ID: 12784694
[TBL] [Abstract][Full Text] [Related]
36. Staging disease severity in movement disorder tauopathies: brain atrophy separates progressive supranuclear palsy from corticobasal degeneration.
Schofield EC; Caine D; Kril JJ; Cordato NJ; Halliday GM
Mov Disord; 2005 Jan; 20(1):34-9. PubMed ID: 15390131
[TBL] [Abstract][Full Text] [Related]
37. Corticobasal degeneration: an autopsy case clinically diagnosed as progressive supranuclear palsy.
Shiozawa M; Fukutani Y; Sasaki K; Isaki K; Hamano T; Hirayama M; Imamura K; Mukai M; Arai N; Cairns NJ
Clin Neuropathol; 2000; 19(4):192-9. PubMed ID: 10919351
[TBL] [Abstract][Full Text] [Related]
38. EEG findings in early-stage corticobasal degeneration and progressive supranuclear palsy: a retrospective study and literature review.
Tashiro K; Ogata K; Goto Y; Taniwaki T; Okayama A; Kira J; Tobimatsu S
Clin Neurophysiol; 2006 Oct; 117(10):2236-42. PubMed ID: 16920021
[TBL] [Abstract][Full Text] [Related]
39. Astrocytic inclusions in progressive supranuclear palsy and corticobasal degeneration.
Yoshida M
Neuropathology; 2014 Dec; 34(6):555-70. PubMed ID: 25124031
[TBL] [Abstract][Full Text] [Related]
40. [Contribution of oculomotor examination for the etiological diagnosis of parkinsonian syndromes].
Pierrot-Deseilligny Ch; Rivaud-Péchoux S
Rev Neurol (Paris); 2003 May; 159(5 Pt 2):3S75-81. PubMed ID: 12773891
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
